During this webinar, experts Valerie Rinkle, MPA, and Laura Lindeman-Lorenz, JD, MHA, MT(ASCP), will review CMS’ current hospital “prohibition of unbundling hospital services” rules as well as the current laboratory DOS policies. They will also explain how to bill for outpatient molecular pathology tests and discuss the differences in inpatient and outpatient billing for these tests.
At the conclusion of this program, participants will be able to: - Explain the changes to the clinical laboratory DOS policies
- Describe the reason the change is applicable to the outpatient but not inpatient setting
- Define the tests impacted by the DOS policy changes
- Outline next steps for implementing DOS-related changes
- Recognize nuances that may impact successful implementation
|
|
|
|
|
Meet the speakers: |
Laura Lindeman-Lorenz, JD, MHA, MT(ASCP), is the CEO of Triple L Health Services Consultants in Newport, Kentucky. She has more than 20 years of broad healthcare experience and deep expertise in clinical laboratory operations. She has led initiatives to improve operations for laboratories ranging from complex academic medical centers to smaller community hospital labs.
|
Valerie A. Rinkle, MPA, is a lead regulatory specialist and instructor for HCPro's Revenue Integrity and Chargemaster Boot Camp®, as well as an instructor for HCPro’s Medicare Boot Camp®—Hospital Version and Medicare Boot Camp®—Utilization Review Version. Rinkle is a former hospital revenue cycle director and has over 30 years in the healthcare industry. |